Pheochromocytoma in a patient with end-stage renal disease

被引:0
|
作者
Godfrey, JA
Rickman, OB
Williams, AW
Thompson, GB
Young, WF
机构
[1] Mayo Clin & Mayo Fdn, Dept Internal Med, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Div Pulm & Crit Care Med & Internal Med, Rochester, MN 55905 USA
[3] Mayo Clin & Mayo Fdn, Div Nephrol & Internal Med, Rochester, MN 55905 USA
[4] Mayo Clin & Mayo Fdn, Div Hypertens & Internal Med, Rochester, MN 55905 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pheochromocytoma is a rare tumor. To our knowledge only 15 cases have been reported in patients with end-stage renal disease (ESRD). We describe a 46-year-old woman with ESRD and a history of paroxysmal and difficult-to-control hypertension. During anesthesia for a surgical procedure, the patient experienced blood pressure lability with systolic blood pressures ranging from 76 to 360 nun Hg. Serum catecholamine concentrations were 2698 pg/mL (reference value, < 750 pg/mL) for norepinephrine, 33 pg/mL (< 110 pg/mL) for epinephrine, and 55 pg/mL (< 30 pg/mL) for dopamine. The concentrations of plasma metanephrines were 6.84 nmot/L (<0.50 nmol/L) for metanephrine and 14.64 nmol/L (<0.90 nmol/L) for normetanephrine. Abdominal computed tomography showed a right-sided, 4-cm mass posterior to the infrahepatic inferior vena cava. Following blood pressure control with alpha- and beta -adrenergic blockade, the mass was removed. Pathologic examination demonstrated the mass was a pheochromocytoma. The maximum postoperative systolic blood pressure was 160 mm Hg. Postoperative plasma normetanephrine concentration was 2.80 nmol/L, and metanephrine was obscured by interfering substances. This case report and literature review emphasizes the difficulty in diagnosing pheochromocytomas in patients with ESRD despite the myriad of available diagnostic tests.
引用
收藏
页码:953 / 957
页数:5
相关论文
共 50 条
  • [31] Hepatitis C infection and the patient with end-stage renal disease
    Fabrizi, F
    Poordad, FF
    Martin, P
    HEPATOLOGY, 2002, 36 (01) : 3 - 10
  • [32] CARE OF THE DIABETIC PATIENT WITH END-STAGE RENAL-DISEASE
    MARKELL, MS
    FRIEDMAN, EA
    SEMINARS IN NEPHROLOGY, 1990, 10 (03) : 274 - 286
  • [33] Rothia dentocariosa bacteremia in a patient with end-stage renal disease
    Al Habib, K
    Werb, R
    Conway, B
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1999, 8 (03) : 170 - 172
  • [34] Vascular calcification in a young patient with end-stage renal disease
    Chan, Winnie K. Y.
    Lee, K. W.
    But, W. M.
    Chau, K. F.
    HONG KONG MEDICAL JOURNAL, 2013, 19 (02) : 178 - 181
  • [35] Black hairy tongue in an end-stage renal disease patient
    Chen, Tz-Heng
    Yu, Hui-Tzu
    Wu, Chien-Hsing
    Lin, Chih-Ching
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2021, 120 (07) : 1531 - 1532
  • [36] Care of the end-stage renal disease patient on dialysis in the ED
    Venkat, Arvind
    Kaufmann, Kristiana R.
    Venkat, K. K.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2006, 24 (07): : 847 - 858
  • [37] CAMPYLOBACTER ARTHRITIS IN A PATIENT WITH END-STAGE RENAL-DISEASE
    ALMOHAYA, SAM
    SAUDI MEDICAL JOURNAL, 1988, 9 (01) : 83 - 85
  • [38] DEVELOPMENT OF MALIGNANCY IN THE END-STAGE RENAL-DISEASE PATIENT
    MARPLE, JT
    MACDOUGALL, M
    SEMINARS IN NEPHROLOGY, 1993, 13 (03) : 306 - 314
  • [39] End-stage renal disease in a patient with congenital lymphangiectasia and lymphedema
    Sombolos, KI
    Papachillea, AI
    Natse, TM
    Gogos, KI
    Pavlidis, GO
    Barboutis, KA
    Mavromatidis, KS
    PEDIATRIC NEPHROLOGY, 2001, 16 (02) : 151 - 153
  • [40] Symptomatic hypercalcemia of immobilization in a patient with end-stage renal disease
    Gopal, H
    Sklar, AH
    Sherrard, DJ
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (05) : 969 - 972